(Reuters) -Telehealth firm Hims & Hers Health said on Tuesday it plans to sell Eli Lilly's diabetes and weight-loss drugs on ...

Telemedicine specialist Teladoc Health (NYSE: TDOC) has been a terrible investment over the past three years. Once the company's pandemic-fueled business boom cooled down, its revenue and visit growth ...

Bullish option flow detected in Teladoc (TDOC) with 7,109 calls trading, 1.3x expected, and implied vol increasing almost 2 points to 78.51%.

Teladoc (TDOC) closed at $7.79 in the latest trading session, marking a +0.39% move from the prior day. The stock lagged the S&P 500's daily gain of 0.67%. On the other hand, the Dow registered a gain ...

Mitsubishi UFJ Trust & Banking Corp lifted its holdings in Teladoc Health, Inc. (NYSE:TDOC – Free Report) by 1,363.0% in the ...

Teladoc Health (NYSE:TDOC) experienced a 10% decline in share price over the past week, despite announcing significant expansions in its connected care partnerships and pharmacy integration agreements ...

Two AI healthcare stocks -- Recursion Pharmaceuticals ( RXRX -2.76%) and Teladoc Health ( TDOC -5.20%) -- have lagged the ...

Despite the still positive FCF generation and richer balance sheet, it remains to be seen when Teladoc's growth may ...

August 1, 2024 Teladoc shares hit record low after telehealth firm withdraws 2024 forecast Teladoc Health's shares closed more than 8% down on Thursday, as surging costs and declining revenue in ...

Teladoc Health has announced an expansion of its connected care partnerships to include new areas such as digestive health, fertility, and specialized care. This growth enhances the company's ...

Telemedicine specialist Teladoc Health (TDOC-5.20%) has been a terrible investment over the past three years. Once the company's pandemic-fueled business boom cooled down, its revenue and visit ...